[The adynamic ileus and its treatment (author's transl)].
D000200:Action Potentials; D002763:Cholecystectomy; D002766:Cholecystokinin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007415:Intestinal Obstruction / Q000188:drug therapy*; D007418:Intestinal Pseudo-Obstruction / Q000188:drug therapy* / Q000503:physiopathology; D007583:Jejunum / Q000503:physiopathology; D009388:Neostigmine / Q000627:therapeutic use; D010418:Pentagastrin / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use*; D010909:Pituitary Hormones, Posterior / Q000627:therapeutic use; D011183:Postoperative Complications / Q000188:drug therapy*
D005765:Gastrointestinal Agents; D010455:Peptides; D010909:Pituitary Hormones, Posterior; D009388:Neostigmine; D002766:Cholecystokinin; D010418:Pentagastrin
L'iléus adynamique et son traitement.